Janux Therapeutics News

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Campbell, Ph.D.(4.8%)

Nov 15 06:15

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(2.0%),Citadel Advisors LLC(1.9%), etc.

Nov 15 05:32

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.

Nov 15 05:29

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

Nov 12 23:38

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(4.1%),Tighe Reardon(3.0%), etc.

Nov 9 07:00

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila

Nov 8 08:13

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L

Nov 8 08:13

Janux Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 05:29

Janux Therapeutics | 8-K: Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 7 05:15

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bregua Corporation(5.8%)

Nov 5 05:11

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 2 05:07

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 2 05:07

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 2 04:33

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 2 04:28

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 2 04:22

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 2 04:12

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan

Oct 31 07:32

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 29 05:09

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 29 05:05

Janux Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 29 04:49